MYRIAD GENETICS INC - Director's Dealing 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2021-07-07

Reporting Person: LANCHBURY JERRY S (Chief Scientific Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-07	Common Stock	M	30424	$26.49	Acquired	262974	Direct
2021-07-07	Common Stock	S	30424	$32.29	Disposed	232550	Direct
2021-07-07	Common Stock	M	1884	$26.49	Acquired	234434	Direct
2021-07-07	Common Stock	S	1884	$31.99	Disposed	232550	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-07	Incentive Stock Option (right to buy)	$26.49	M	1884	Disposed	2021-09-17	Common Stock (1884)	Direct
2021-07-07	Non-Qualified Stock Option (right to buy)	$26.49	M	30424	Disposed	2021-09-17	Common Stock (30424)	Direct

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2: The shares subject to this option are fully vested and exercisable.